Akili (NASDAQ:AKLI) Price Target Raised to $4.50 at Credit Suisse Group

Akili (NASDAQ:AKLIGet Rating) had its price target increased by Credit Suisse Group from $4.00 to $4.50 in a research report sent to investors on Tuesday, Marketbeat reports. Credit Suisse Group currently has an outperform rating on the stock.

Other equities research analysts also recently issued reports about the stock. Cowen assumed coverage on shares of Akili in a research note on Tuesday, September 6th. They issued an outperform rating for the company. Lifesci Capital reiterated an outperform rating on shares of Akili in a research note on Tuesday, September 6th. Finally, Cowen initiated coverage on shares of Akili in a research note on Tuesday, September 6th. They set an outperform rating for the company.

Akili Price Performance

Shares of AKLI opened at $1.83 on Tuesday. Akili has a twelve month low of $1.57 and a twelve month high of $37.58. The company has a 50 day moving average price of $2.57.

Institutional Investors Weigh In On Akili

Institutional investors and hedge funds have recently made changes to their positions in the stock. Tower Research Capital LLC TRC acquired a new stake in shares of Akili during the third quarter worth $32,000. Longitude Cayman Ltd. purchased a new position in shares of Akili during the third quarter worth $34,000. Northeast Financial Consultants Inc purchased a new position in shares of Akili during the third quarter worth $128,000. YHB Investment Advisors Inc. purchased a new position in shares of Akili during the third quarter worth $209,000. Finally, Revelation Capital Management LLC purchased a new position in shares of Akili during the third quarter worth $556,000. 89.24% of the stock is currently owned by institutional investors and hedge funds.

Akili Company Profile

(Get Rating)

Akili, Inc, a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.

Read More

Receive News & Ratings for Akili Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akili and related companies with MarketBeat.com's FREE daily email newsletter.